Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

NCT01758458 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped A Phase I/II study (NCT01758458) is now recruiting

Conditions

Recurrent Merkel Cell Carcinoma
Stage IV Merkel Cell Carcinoma

Interventions

BIOLOGICAL: Aldesleukin
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells
RADIATION: Radiation Therapy
BIOLOGICAL: Recombinant Interferon Beta

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]